Fluorinated pyrrolo[2,3-d]pyrimidine nucleosides for the treatment of RNAdependent RNA viral infection

Details for Australian Patent Application No. 2005317081 (hide)

Owner Merck & Co., Inc.

Inventors Maccoss, Malcolm; Olsen, David B.; Durette, Philippe L.; Leone, Joseph

Agent Spruson & Ferguson

Pub. Number AU-A-2005317081

PCT Pub. Number WO2006/065335

Priority 60/651,366 09.02.05 US; 60/620,743 21.10.04 US

Filing date 17 October 2005

Wipo publication date 22 June 2006

International Classifications

A61K 31/7072 (2006.01)

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/065335 Priority application(s): WO2006/065335

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005317086-Arrangement of daisy chained inductive couplers for data communication

2005317079-Air compressor control